Porton J-STAR has announced that Enabling Technologies Consortium (ETC) has awarded a two-year contract to J-STAR to collaborate on ‘Co-processing Platform Technology’. #healthcare #PharmaIndustrialIndia
Pharma Industrial India’s Post
More Relevant Posts
-
There is a rising need for enabling drug delivery technology platforms that address delivery solutions for novel therapies. With resuspension technology, SMC’s Vita autoinjector provides a potential solution for the technically challenging delivery needs for Long-Acting Injectables. Read our latest publication: “An Enabling Autoinjector Technology For Delivery of Long-acting Injectables” in the latest issue of ONdrugDelivery by Asmita Khanolkar and Susanna White. https://hubs.la/Q02gPHfH0
To view or add a comment, sign in
-
-
Read our latest publication: “An Enabling Autoinjector Technology For Delivery of Long-acting Injectables” in the latest issue of ONdrugDelivery by Asmita Khanolkar and Susanna White. https://hubs.la/Q02gPHfH0
There is a rising need for enabling drug delivery technology platforms that address delivery solutions for novel therapies. With resuspension technology, SMC’s Vita autoinjector provides a potential solution for the technically challenging delivery needs for Long-Acting Injectables. Read our latest publication: “An Enabling Autoinjector Technology For Delivery of Long-acting Injectables” in the latest issue of ONdrugDelivery by Asmita Khanolkar and Susanna White. https://hubs.la/Q02gPHfH0
To view or add a comment, sign in
-
-
𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚 𝐒𝐮𝐩𝐩𝐥𝐲 𝐂𝐡𝐚𝐢𝐧 & 𝐋𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 𝐁𝐨𝐬𝐭𝐨𝐧 2023 🔔 New Speaker Alert for #PPSLSUMMIT 📢 We are delighted to welcome Nicholas Rioux of Labviva to the event. Presentation Outline: With a growing number of disconnected systems in pharmaceutical research and design procurement, the resulting stack of challenges looms large. It includes a lack of transparency into your organization’s supplies, a fragmented user experience, and cost inefficiencies. This session outlines the root causes behind today’s most significant procurement challenges, defines the required characteristics to successfully defeat these problems, and offers strategic, actionable steps you can take today to resolve them with a unification system. 📅 Save the Date: November 16th-17th, 2023 🏢 Venue: DoubleTree Suites by Hilton Boston-Cambridge For inquiries, feel free to reach out to us at [email protected]. #ClinicalTrials #MedicalDevices #LifeSciences #Summits #InPersonEvents #Exhibition #Sponsors #Networking #USAClinicalTrialSummits #USAMedDeviceSummits #Medtech #DCT #AI #ML #Data #Biostats #VideoFootage #Device #Clinical #RegulatoryAffairs #DigitalMarketing #HotelVenue #Medicine #Health #DCT #AI #ML #digitalhealth #LifeScienceSummits #ClinicalTrialSummits #DrugDiscoverySummits #MedicalDevicesSummits #decentralizedclinicaltrialsevents #PreclinicalSummits #MedTechSummits #DigitalHealthSummits #USAClinicalTrialEvents #USADrugDiscoverySummits #PharmaSupplyChainSummits #DrugDiscoverySummits #EuropeanClinicalTrialSummits
To view or add a comment, sign in
-
-
Personalized Medicine Revolution AI in Drug Discovery Telepharmacy: Remote Care Sustainable Pharma Practices Everyone should read them. They’re timeless. Dive deeper into these innovative tales and see how they're reshaping healthcare! Share your thoughts or tag a friend who's into health innovation. 🤓💊 #InnovationInPharma #HealthcareFuture #PharmaceuticalServices #AllwaysPharma
To view or add a comment, sign in
-
-
While the execution of #clinicaltrials is faltering due to a lack of swift and efficient outreach and engagement, this then results in exorbitant trial costs, which often has a ripple effect on drop-out rates. Amid these challenges, industry experts advise a robust and productive strategy to maximize engagement safety and minimize risks. Adopting #decentralizedtrial technologies is one of them. Learn how modernising Clinical Trials though the PARTICIPATE framework is an ideal description that can add momentum to clinical trials and elevate clinical trial with successful outcomes. To know more, read pharmaphorum's news article: https://hubs.la/Q02b9CW_0 #diversity #biotech #patientaccess #RWE #ePRO #patientengagement
To view or add a comment, sign in
-
-
Advancing Life-Changing Medicines as President of Project Farma (PF) and Precision for Medicine Manufacturing Solutions
The #celltherapy industry faces unique challenges, including complex #manufacturing processes and high development costs, creating hurdles in #accessibility and efforts to scale these therapies. #Gilead and other companies are working to streamline procedures, reduce turnaround times, and expand local access in rural areas. Considering production needs during the #clinicalstage and allocating investments towards manufacturing infrastructure early are critical factors for success in this field. As developers search for solutions, stakeholders should consider exploring #allogeneic options and targeting niche markets like severe #autoimmunediseases to continue making progress in this field. This innovative technology has the potential to transform the lives of patients. Industry leaders are dedicated to this mission and continue pressing forward with innovative #trialdesigns and are collaborating closely with #regulatory bodies to overcome these hurdles to deliver life saving treatments to patients.
To view or add a comment, sign in
-
-
Pharma and Healthcare Industry Analysis - 2030 By 2030, the pharmaceutical and healthcare industry is projected to grow substantially, with a compound annual growth rate (CAGR) expected to exceed 5%. This growth is driven by increasing global healthcare expenditure, anticipated technological advancements in AI and biotechnology, and expanding healthcare infrastructure in both developed and emerging markets. Regulatory reforms aimed at enhancing drug approval processes and improving patient access to innovative therapies are also contributing factors. Furthermore, the industry's pivot towards personalized medicine and digital health solutions is set to transform patient care delivery, emphasizing improved outcomes and cost-effectiveness. Overall, the sector is poised for robust expansion, supported by innovations and strategic investments, promising significant opportunities and advancements by 2030. Top Companies in Pharma and Healthcare ➢ Rx Savings Solutions ➢ Amplifon Hearing Health Care ➢ LinkLive ➢ CERES Group ➢ Produce Alliance, LLC. ➢ Charles Aris Executive Search ➢ ClearDATA ➢ Pager Health ➢ Hadassah ➢ Haselden Construction ➢ Harkins Builders, Inc. ➢ COTA ➢ Dreamit Ventures ➢ MedTrainer ➢ Network ESC A Division of Network Temps, Inc. ➢ iMind Business Consulting Inc. | iMind Your Business ➢ Softheon ➢ BVS ➢ SnapCare ➢ IA Collaborative ➢ Thornton Construction Company, Inc. ➢ Archway Health ➢ Management Solutions ➢ Blue Health Intelligence ➢ Northwestern University - Kellogg School of Management ➢ RXNT ➢ Hoverstate, a SoftServe company ➢ ViitorCloud Technologies ➢ Software Finder ➢ Dimeo Construction Company ➢ Dellbrook | JKS ➢ EHE Health ➢ Nexis Network Blockchain ➢ SUPERIORHIRE ➢ AnsibleHealth ➢ AIMed ➢ The LOOMIS Agency ➢ PayrHealth #Pharma #Healthcare #Pharmaceuticals #Biotechnology #MedicalDevices #HealthTech #ClinicalTrials #HealthcareInnovation #DrugDiscovery #MedicalResearch #HealthcareIT #DigitalHealth #PatientCare #Biopharma #PrecisionMedicine #HealthcareAnalytics #PharmaMarketing #HealthcareProfessional #HealthPolicy #PharmaIndustry
To view or add a comment, sign in
-
-
Pharma and Healthcare Industry Analysis - 2030 By 2030, the pharmaceutical and healthcare industry is projected to grow substantially, with a compound annual growth rate (CAGR) expected to exceed 5%. This growth is driven by increasing global healthcare expenditure, anticipated technological advancements in AI and biotechnology, and expanding healthcare infrastructure in both developed and emerging markets. Regulatory reforms aimed at enhancing drug approval processes and improving patient access to innovative therapies are also contributing factors. Furthermore, the industry's pivot towards personalized medicine and digital health solutions is set to transform patient care delivery, emphasizing improved outcomes and cost-effectiveness. Overall, the sector is poised for robust expansion, supported by innovations and strategic investments, promising significant opportunities and advancements by 2030. Top Companies in Pharma and Healthcare ➢ Rx Savings Solutions ➢ Amplifon Hearing Health Care ➢ LinkLive ➢ CERES Group ➢ Produce Alliance, LLC. ➢ Charles Aris Executive Search ➢ ClearDATA ➢ Pager Health ➢ Hadassah ➢ Haselden Construction ➢ Harkins Builders, Inc. ➢ COTA ➢ Dreamit Ventures ➢ MedTrainer ➢ Network ESC A Division of Network Temps, Inc. ➢ iMind Business Consulting Inc. | iMind Your Business ➢ Softheon ➢ BVS ➢ SnapCare ➢ IA Collaborative ➢ Thornton Construction Company, Inc. ➢ Archway Health ➢ Management Solutions ➢ Blue Health Intelligence ➢ University of Northwestern Ohio ➢ RXNT ➢ Hoverstate, a SoftServe company ➢ ViitorCloud Technologies ➢ Software Finder ➢ Huli ➢ Dimeo Construction Company ➢ Dellbrook | JKS ➢ EHE Health ➢ Nexis Network Blockchain ➢ SUPERIORHIRE ➢ AnsibleHealth ➢ AIMed ➢ The LOOMIS Agency ➢ QHR ➢ PayrHealth #Pharma #Healthcare #Pharmaceuticals #Biotechnology #MedicalDevices #HealthTech #ClinicalTrials #HealthcareInnovation #DrugDiscovery #MedicalResearch #HealthcareIT #DigitalHealth #PatientCare #Biopharma #PrecisionMedicine #HealthcareAnalytics #PharmaMarketing #HealthcareProfessional #HealthPolicy #PharmaIndustry
To view or add a comment, sign in
-
-
Pharma and Healthcare Industry Analysis - 2030 By 2030, the pharmaceutical and healthcare industry is projected to grow substantially, with a compound annual growth rate (CAGR) expected to exceed 5%. This growth is driven by increasing global healthcare expenditure, anticipated technological advancements in AI and biotechnology, and expanding healthcare infrastructure in both developed and emerging markets. Regulatory reforms aimed at enhancing drug approval processes and improving patient access to innovative therapies are also contributing factors. Furthermore, the industry's pivot towards personalized medicine and digital health solutions is set to transform patient care delivery, emphasizing improved outcomes and cost-effectiveness. Overall, the sector is poised for robust expansion, supported by innovations and strategic investments, promising significant opportunities and advancements by 2030. Top Companies in Pharma and Healthcare ➢ @Rx Savings Solutions ➢ @Amplifon Hearing Health Care ➢ @LinkLive ➢ @CERES Group ➢ Produce Alliance, LLC. ➢ Charles Aris Executive Search ➢ ClearDATA ➢ Pager Health ➢ Hadassah ➢ Haselden Construction ➢ Harkins Builders, Inc. ➢ COTA ➢ Dreamit Ventures ➢ MedTrainer ➢ Network ESC A Division of Network Temps, Inc. ➢ iMind Business Consulting Inc. | iMind Your Business ➢ Softheon ➢ BVS ➢ SnapCare ➢ IA Collaborative ➢ Thornton Construction Company, Inc. ➢ Archway Health ➢ Management Solutions ➢ Blue Health Intelligence ➢ University of Northwestern Ohio ➢ RXNT ➢ Hoverstate, a SoftServe company ➢ ViitorCloud Technologies ➢ Software Finder ➢ Huli ➢ Dimeo Construction Company ➢ Dellbrook | JKS ➢ EHE Health ➢ Nexis Network Blockchain ➢ SUPERIORHIRE ➢ AnsibleHealth ➢ AIMed ➢ The LOOMIS Agency ➢ QHR ➢ PayrHealth #Pharma #Healthcare #Pharmaceuticals #Biotechnology #MedicalDevices #HealthTech #ClinicalTrials #HealthcareInnovation #DrugDiscovery #MedicalResearch #HealthcareIT #DigitalHealth #PatientCare #Biopharma #PrecisionMedicine #HealthcareAnalytics #PharmaMarketing #HealthcareProfessional #HealthPolicy #PharmaIndustry
To view or add a comment, sign in
-